Chronic myeloid leukemia in 2007

American Journal of Health-System Pharmacy

Volumn 64, Issue 24 SUPPL., 2007, Pages

  Sessions, Jolynn ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Antineoplastic agents; Diagnosis; Epidemiology; Leukemia; Mechanism of action; Mortality; Resistance; Site of action

Indexed keywords

BCR ABL PROTEIN; IMATINIB; PROTEIN TYROSINE KINASE;

BLOOD CELL COUNT; CANCER EPIDEMIOLOGY; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CLONE; CONFERENCE PAPER; CYTOGENETICS; DISEASE COURSE; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; KARYOTYPING; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 37249001805     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070484     Document Type: Conference Paper

References (13)

1. Cancer Facts & Figures. www.cancer.org/downloads/STT/ CAFF2007PWSecured.pdf (accessed 2007 July 15).
2. Sawyers CL. Chronic myeloid leukemia. N Engl J Med. 1999; 340:1330-40.
3. Druker BJ, Guilhot F, O'Brien SG et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006; 355:2408-17.
4. O'Brien SG, Guilhot F, Larson RA et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003; 348:994-1004.
5. Sokal JE, Baccarani M, Russo D et al. Staging and prognosis in chronic myelogenous leukemia. Semin Hematol. 1988; 25:49-61.
6. Faderl S, Talpaz M, Estrov Z et al. Chronic myelogenous leukemia: biology and therapy. Ann Intern Med. 1999; 131:207-19.
7. Jaffe ES, Harris NL, Stein H et al. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumors. Lyon, France: IARC Press; 2001.
8. Savage DG, Szydlo RM, Chase A et al. Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse. Br J Haematol. 1997; 99:30-5.
9. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497.
10. Pane F, Intrieri M, Quintarelli C et al. BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene. 2002; 21:8652-67.
11. Mitelman F. The cytogenetic scenario of chronic myeloid leukemia. Leuk Lymphoma. 1993; 11(suppl 1):11-15.
12. Fioretos T, Strombeck B, Sandberg T et al. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood. 1999; 94:225-32.
13. NCC Network. NCCN Practice Guidelines in Oncology, 2008. www.nccn.org (accessed 2007 August 6).